BioSpace News Archive

Antibody Services Market Trends – Rise in Research and Development Activities in the Pharmaceutical and Biotechnology Industries

Increasing prevalence of infectious diseases and growing adoption of targeted immunotherapy are some of the key factors driving the global market revenue growth.

May 10, 2022
·
6 min read
High-performance Liquid Chromatography (HPLC) Market Trends – Increasing Research & Development Projects in the Pharmaceutical, Biotechnology and Food & Beverage Industries

Increasing applications of the high-performance liquid chromatography technique in biological R&D activities and growing number of clinical trials are among the major factors expected to drive the global market revenue growth.

May 10, 2022
·
6 min read
In-Situ Hybridization Market Trends – Increasing Use of In-Situ Hybridization to Detect Response to Therapy in Certain Types of Cancer Cells

Rapidly rising prevalence of chronic and genetic diseases, increasing advancements in molecular biology techniques, and rising investments to accelerate cancer research studies are some key factors expected to drive market growth.

May 10, 2022
·
7 min read
Healthcare Logistics Market Size 2022-2030 - Industry Revenue Growth Is Being Driven By Constant Expansion Of Healthcare Infrastructure Around The World

The industry analysis report is considered a valuable source of information about the global Healthcare Logistics industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

May 10, 2022
·
7 min read
Real-World Evidence Solutions Market Insights, Future Trends, On-going Demand, Opportunities, Segmentation, and Forecast Till 2030

The industry analysis report is considered a valuable source of information about the global Real-World Evidence Solutions industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

May 10, 2022
·
7 min read
Deals

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”) and Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) today announced the closing of the initial public offering (“IPO”) of Bausch + Lomb.

May 10, 2022
·
5 min read
Biotech Bay

ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab and Neuronal Itch Mechanisms for Poster Presentation at the 2022 Society for Investigative Dermatology Annual Meeting

ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract highlighting new data and insights related to neuronal itch mechanisms through eblasakimab’s targeting of IL-13Rα1 has been accepted for late-breaking poster presentation at the Society for Investigative Dermatology (SID) Annual Meeting.

May 10, 2022
·
2 min read
Business

API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses

Applied Pharmaceutical Innovation, a not-for-profit life sciences organization has partnered with a team of scientists from the University of Waterloo, to conduct research in finding promising therapeutics and drugs for the treatment and prevention of coronaviruses.

May 10, 2022
·
3 min read
Business

Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights

Lyell Immunopharma, Inc., a T-cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, provided business highlights and reported financial results for the first quarter of 2022.

May 10, 2022
·
11 min read
Business

Evoke Pharma Reports First Quarter 2022 Financial Results

Evoke Pharma, Inc. announced its financial results for the first quarter ended March 31, 2022, and recent corporate developments.

May 10, 2022
·
10 min read